Several studies have reported the beneficial effects of Lawsonia inermis on wound healing, but the mechanism of action is still unknown. This study aimed to investigate the effectiveness of a new ointment formulation of hydroethanolic extract leaves of phase, accelerated cellular proliferation, and enhanced wound contraction ratio. It also improved revascularization, collagen deposition, and re-epithelialization rate and promoted intracytoplasmic carbohydrate storage (P < 0.05). Moreover, the mRNA levels of Igf-1 and Glut-1 were significantly higher in the L. inermis-treated groups than the control group (P < 0.05). Topical administration of L. inermis promoted the healing process by reducing tissue inflammation and increasing glucose uptake, which was mediated by up-regulating the expression of Igf-1 and Glut-1.
| INTRODUCTION
Wound healing is a complicated physiological process comprising of different stages including inflammatory or exudative/debridement, proliferative or fibroplasia and remodeling or maturation phases. 1 Carbohydrates have key roles in wound healing process, because they participate in production of bi-products such as glycosaminoglycans, glycoproteins, and enzymes that are significantly effective in wound healing. 2 Glucose is used as fuel by inflammatory cells in order to remove bacteria and reduce necrotic material. 3 It has also been shown that physiologic glucose uptake supplies energy for proliferation, migration, and differentiation of keratinocytes at final stage of wound healing. 4 However, hyperglycemia inhibits physiological interactions, proliferation, and migration of keratinocytes during wound healing process. The glucose transporter proteins are known to be the key structures in transferring glucose into mammalian cells. Glucose transporter-1 (Glut-1) is not only responsible for basal glucose uptake but also encourages cell proliferation and migration by regulating epidermal growth factor receptor in cancer cells. 5 Insulin-like growth factor I (Igf-1) is not only transported glucose into cell during wound healing but also modulated cell proliferation and migration during the fibroplasia stage of wound healing in rats. 6 It has also been known to be a key factor in myofibroblast differentiation and proliferation because of its mitogenic activity. 7 Several synthetic chemical products are used in wound healing, but they have major limitations such as the complications and side effects. 8 Medicinal plants and their derivatives are safe substances and received much attention in treatment of wound healing. The
Lawsonia inermis (henna) constituents are made up of phenolic compounds, tannic acid, fatty acid, and gallic acid. 9 It is known to have some pharmaceutical properties such as antibacterial, antioxidant, and anti-inflammatory activities. 10 Several studies have shown that administration of henna promotes wound healing process, but the mechanism of action has not been distinguished yet. 11, 12 Considering the role of glucose in accelerating wound healing and also the role of Igf-1 and Glut-1 in transporting glucose into cells, this in vivo study was conducted in order to clarify the effectiveness of L. inermis in wound healing by evaluating the expression of the Igf-1, Glut-1 genes, and histomorphometric parameters. 
| METHODS

| Preparation of the extract
| Antioxidant activity of the extract
2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl (DPPH) free radical inhibition was assessed as described by Chen et al. 13 It was firstly incubated at 25 C for 45 minutes and the absorbance was then recorded at 517 nm, using a PowerWave XS microplate spectrophotometer. Free radical inhibition (%) was calculated as follows:
A blank and A sample are the absorbance capability of the control reaction and the absorbance capability of the test compound, respectively.
After obtaining the concentration in 50% restrained (IC 50 ), it was calculated from the graph of inhibition percentage plotted against concentration of samples.
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T A B L E 
| Standardization and estimation of total flavonoids
The total phenolic constituent sample extract was determined as described by Farahpour et al using Folin-Ciocalteu reagent and gallic acid (ranging from 0 to 1000 mg/L) as template phenolic compound. 1 
| Animals and study design
Male Wistar rats, 9-weeks-old, were housed in plastic cages and accustomed with testing area in order to minimize anxiety for 2 weeks prior to the study. All the procedures were approved by the Ethical Committee of Islamic Azad University, Urmia Branch (No. IAUU 1013).
| Circular excisional wound model
Induction of wound was done as described by Farahpour et al. %wound size = wound area on day X ð Þ wound area on day 0 × 100:
| Histological analysis
Histopathological analyses were done as explained by Farahpour et al. 15 Briefly, the animals were euthanized on the 3rd, 7th, 14th
and 20th day after wounding, and full thickness tissue samples with 1-2 mm from the surrounding normal skin were excised and fixed in neutral-buffered 10% formalin, dehydrated by graded ethanol, cleared by xylol, embedded with paraffin wax, sectioned at 5 μm in thickness and stained with Masson's trichrome. Immunohistochemical (IHC) analysis was performed for macrophages (CD68). The samples stained by periodic acid-Schiff (PAS) for intracytoplasmic carbohydrate and alkaline phosphatase (ALP) staining were used for tissue inflammation. Inflammatory cell infiltration and fibroblasts/fibrocytes proliferation, edema, and collagen density were evaluated in each tissue section. Edema in all groups was analyzed as described by Farahpour et al. 15 All parameters were analyzed in five per high power fields and the epithelial thickness was evaluated by morphometric lens (Olympus, Tokyo, Japan). 
T A B L E 2 Histomorphometric analyses in different groups
| Statistical analyses
All analyses were performed using PASW version 18.0. Two-way ANOVA was used to analyze the results. Dunnett's test for pair-wise comparisons was used to assess the effect of time and treatments.
Differences were considered significant if P < 0.05.
| RESULTS
| Antioxidant activity, total phenol and flavonoid contents
Biochemical analyses for DPPH inhibition assay showed that the hydroethanolic extract of L. inermis exhibited significantly higher potential (0.2178 μg/mL) in comparison to butylated hydroxytoluene (107.04 μg/mL). More analyses for phenol and flavonoid content showed higher antioxidant power for the L. inermis leaves extract. In addition, the dried extract of L. inermis contained remarkable amounts of phenol (69.92 ± 2.34 μg/mg) and flavonoid (37.7 μg eq Rutin/mg).
| Wound contraction and re-epithelialization
The wound area was significantly (P < 0.05) smaller in the L. inermistreated groups, especially at 6% dose, compared to the control group F I G U R E 1 Photomicrograph from skin on day 7 after wound creation: A, control; B, 1.5% Lawsonia inermis-treated; C, 3% L. inermis-treated; and D, 6% L. inermis-treated groups. The macrophages are presented with positive reaction for chromogen. Note intensive macrophage infiltration in the L. inermis-treated animals. Immunohistochemistry for CD68 (×200) from day 6 until day 20 ( Table 2 ). The animals in the L. inermistreated groups, particularly the 6% dose, pronouncedly showed re-epithelialization on day 6 after wound induction. Complete epithelialization was revealed in the L. inermis-treated groups on day 18 after wound induction, which was observed on day 20 in the control group (Table 1) .
Mean distribution of (A) fibroblasts and (B) fibrocytes per mm 2 wound area. All data are expressed in mean ± SD. The superscript letters a and b represent significant differences between marked data (P < 0.05) F I G U R E 3 Photomicrograph from the wound area: A1 and A2, control; B1 and B2, 1.5% Lawsonia inermis-treated; C1 and C2, 3% L. inermis-treated; and D1 and D2, 6% L. inermis-treated groups. The first raw represent the wound area on day 3 after wound creation. Note the well-formed granulation tissue with increased collagen biosynthesis in the L. inermis-treated cross sections. The second raw represents re-epithelialization and dermal maturation. See collagen alignment associated with normal epithelialization in the 3% and 6% L. inermis-treated groups. Masson-trichrome staining (×800 and ×400)
| Histopathological findings
Topical administration of 3% and 6% L. inermis reduced the edema scores on 3 and 7 days after wound creation ( Table 2 ). All doses of L. inermis remarkably (P < 0.05) enhanced new blood vessel formation in the wound bed ( Table 2) . Administration of 3% and 6% L. inermis reduced inflammatory cells infiltration (Table 2 ) and also IHC staining (Figure 2A,B) and the collagen density and re-epithelization were improved in the L. inermis-treated groups compared to the control one (Figure 3 ).
| Intracytoplasmic carbohydrates in keratinocytes
Histochemical PAS staining showed that L. inermis dose dependently upregulated the intracytoplasmic carbohydrate storage. The fibroblasts and fibrocytes of the animals treated with 6% L. inermis exhibited intensive reaction to PAS staining compared to other L. inermis-treated groups (P < 0.05). Light microscopic analyses for carbohydrate foci in epithelial cells showed that the animals in the L. inermis-treated groups, dose dependently, showed better reaction to PAS staining (Figure 4 ).
| Inflammatory reaction
Lawsonia inermis significantly reduced the distribution of ALP-positive cells compared to the control animals. Accordingly, the animals in the 6% L. inermis-treated group exhibited significantly (P < 0.05) lower ALP-positive cell distribution compared to the 1.5% and 3% L. inermistreated and control groups ( Figure 5 ).
3.6 | The Igf-1 and Glut-1 mRNA level
The data for reverse-transcription PCR (RT-PCR) showed that topical administration of L. inermis increased (P < 0.05) the level of Igf-1 mRNA on the seventh day after wound induction ( Figure 6A,B) . In addition, the expression level of Glut-1 significantly elevated in the 3% and 6%
L. inermis-treated groups at 7 days after wound creation (P < 0.05) ( 
| DISCUSSION
The L. inermis leaves had antioxidant property and accelerated the wound healing process by mitigating the inflammatory phase. Antioxidants decrease malondialdehyde, decrease the lipid peroxidation ratio and RNA and DNA oxidation 16 and finally improve wound healing. Antioxidants are known to have considerable impact on the healing process by reducing the inflammatory stage. 17 The inflammatory phase is the main step in eliminating cell debris, secretion of various cytokines and matrix metalloproteinases and occurrence of extensive response to microbial infection. 18 Our IHC analyses also showed that L. inermis significantly reduced distribution of the ALP-positive cells in the wound area.
Thus, topical application of L. inermis rapidly initiated inflammation by higher inflammatory cell infiltration and subsequently reduced the inflammatory phase compared to the control animals. Neutrophils, macrophages, and lymphocytes are infiltrated to the site of wound during inflammatory stage. 19 On the other hand, the plant extracts prevent monocyte-to-macrophage differentiation. 20 Thus, L. inermis may decrease inflammatory phase by inhibiting monocyte-to-macrophage differentiation. Increased time of inflammatory phase delays the proliferation and maturation stages. Thus, L. inermis accelerates the wound healing process from inflammatory phase toward proliferative phase.
Rapid cellular proliferation and differentiation is essential in shortening the healing time. 21 Up-regulated revascularization in association with increased collagen deposition is necessary in order to accelerate the healing process. 22 Fibroblasts and fibrocytes are the main cells in producing collagen and glycosaminoglycans. 1 In the fibroplasia phase of healing, higher doses of L. inermis (3% and 6%) enhanced proliferation F I G U R E 6 A, mRNA expression of insulin-like growth factor I (Igf-1) and glucose transporter-1 (Glut-1) in different experimental and control groups. Topical administration of Lawsonia inermis elevated the Igf-1 and Glut-1 mRNA expression level in comparison with the control group. The animals in the 6% L. inermis-treated group showed significantly higher mRNA level based on GAPDH intensity (P < 0.05). B and C, Igf-1 and Glut-1/GAPDH intensity, all data are expressed in mean ± SD. The superscript letters a, b, c, and d represent significant differences between the marked data and differentiation of fibroblasts and deposition of collagen at 7 days after wound creation. Thus, L. inermis helps in production of collagen deposition by proliferation, differentiation, and migration of fibroblasts and fibrocytes.
Administration of L. inermis seems to accelerate epithelialization by provoking carbohydrates, especially glucose, reduce the distance between the wound edges and promote re-epithelialization to shorten the necessary time for wound closure. In line with the present findings, our previous study showed that the hydroethanolic Allium sativum extract shorten the healing process by increasing the intracytoplasmic carbohydrate ratio. 23 Glucose has been known to have important role in supporting the energy source for keratinocyte migration and proliferation by glycolysis pathway. 4 Our microscopic PAS analyses showed that administration of 3% and 6% L. inermis increased the intracytoplasmic carbohydrate ratio compared to the control animals demonstrating increased glucose uptake in the L. inermis-treated groups. In addition, the RT-PCR results confirmed that L. inermis facilitated the glucose transport by up-regulating the Glut-1 expression. In line with the IHC and RT-PCR analyses, the results showed that the rate of glucose transport as well as the expression levels of Glut-1 were increased in the L. inermis-treated groups, so that the proliferated keratinocytes had the highest glucose transport rate marked with PAS staining in the L. inermis-treated groups.
It can be concluded that L. inermis affected re-epithelialization mainly in the keratinocytes level.
The data for Igf-1 expression level confirmed the effects of L. inermis on proliferation of fibroblasts and keratinocytes. It has been shown that local delivery of Igf-1 accelerated healing in the senescent mice and tissue ischemic model rats. 20 In addition, Igf-1 enhances proliferation and migration of both keratinocytes and fibroblasts in vitro. 24 It can be stated that L. inermis by up-mediating and regulating the Igf-1 expression enhanced proliferation of fibroblasts and keratinocytes by enhancing glucose uptake. It is also accepted that antioxidants promote cell proliferation at fibroplasia phase of wound healing. 16 It seems the antioxidant property of the L. inermis leaves has a crucial role in accelerating the proliferative stage of wound healing.
Therefore, administration of L. inermis shortened the inflammatory phase and then enhanced proliferation and differentiation of fibroblasts and deposition of collagen fibers. L. inermis also enhanced glucose uptake by up-regulating the Igf-1 and Glut-1 expression to promote wound healing. We recommend using Glut-1 and Igf-1 silencing microRNAs in order to obtain more precise results in future studies.
